Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today it is voluntarily expanding its March 31, 2010, recall of Propofol Injectable Emulsion 1% and Liposyn™ (Intravenous Fat Emulsion) products which include Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, and Liposyn III 30% to the consumer or user level.
Hospira is conducting the recall because some of the containers may contain particulate matter.
medication deliveryHospira Announces an Expansion of a Nationwide Voluntary Recall ...Food and Drug Administration--Recalls Fri, 05/28/2010 - 12:30
Baxter Executives and the Syndrome of Overconfidence in the Chin...Health Care Renewal Wed, 03/26/2008 - 13:24
At various posts on Baxter's contaminated heparin, Roy Poses makes a number of good points. I will amplify one I consider crucial, and perhaps sentinel:
|
